ConMed Corp. (NYSE: CNMD), a surgical-device maker originally headquartered in the Utica region, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents per share for the first quarter of 2025. The dividend is payable on April 4, to all shareholders of record as of March 14. At the […]
ConMed Corp. (NYSE: CNMD), a surgical-device maker originally headquartered in the Utica region, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents per share for the first quarter of 2025.
The dividend is payable on April 4, to all shareholders of record as of March 14. At the company’s current stock price, the payment yields about 1.1 percent on an annual basis.
ConMed is a medical technology company that provides devices and equipment for surgical procedures. The firm’s products are used by surgeons and other health-care professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
Based in Largo, Florida since 2021, ConMed still operates a facility on French Road in New Hartford, where it was formerly headquartered.
